Supplementary Table S2 from RBM10 Loss Promotes EGFR-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition

Supplementary Table S2

Bewaard in:

Bibliografische gegevens
Hoofdauteur:	Yufang Bao (15386826) (author)
Andere auteurs:	Sirui Zhang (15386829) (author), Xiaoyu Zhang (15386832) (author), Yunjian Pan (15386835) (author), Yueren Yan (15386838) (author), Ning Wang (15386841) (author), Yunpeng Ren (15386844) (author), Ji Zuo (15386847) (author), Wei-Xing Zong (15386850) (author), Zefeng Wang (15386853) (author), Yongbo Wang (15386856) (author)
Gepubliceerd in:	2025
Onderwerpen:	Cancer Cancer Biology Molecular and Cellular Biology Therapeutic Research and Development Methods and Technology Computational Methods Sequence analysis Drug Resistance Regulation of gene expression in drug resistance Reversal of drug resistance Gene Regulation Posttranscriptional and translational control Lung Cancer Oncogenes & Tumor Suppressors Tumor suppressor genes Preclinical Models Animal models of cancer
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!

Supplementary Table S2 from <i>RBM10</i> Loss Promotes <i>EGFR</i>-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition